VRCA (STOCKS)
Verrica Pharmaceuticals Inc. Common Stock
$4.860000
-0.230000 (-4.52%)
Prev close: $5.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jayson M. Rieger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $84.18M
- Employees
- 71
- P/E (TTM)
- -2.91
- P/B (TTM)
- 20.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $30.32M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $58.70M |
| Nonoperating Income/Loss | -$2.81M |
| Operating Expenses | $58.70M |
| Selling, General, and Administrative Expenses | $37.86M |
| Research and Development | $14.62M |
| Other Operating Expenses | $6.22M |
| Operating Income/Loss | -$28.38M |
| Income/Loss From Continuing Operations After Tax | -$31.18M |
| Income/Loss From Continuing Operations Before Tax | $15.62M |
| Net Income/Loss | -$31.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.75 |
| Diluted Earnings Per Share | -$1.75 |
| Basic Average Shares | 53,263,327 |
| Diluted Average Shares | 53,263,327 |
| Assets | $36.02M |
| Current Assets | $32.64M |
| Inventory | $2.71M |
| Other Current Assets | $29.93M |
| Noncurrent Assets | $3.38M |
| Fixed Assets | $177.00K |
| Other Non-current Assets | $3.20M |
| Liabilities | $31.71M |
| Current Liabilities | $22.44M |
| Accounts Payable | $1.60M |
| Wages | $1.62M |
| Other Current Liabilities | $19.22M |
| Noncurrent Liabilities | $9.27M |
| Equity | $4.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.31M |
| Liabilities And Equity | $36.02M |
| Net Cash Flow From Operating Activities | -$13.35M |
| Net Cash Flow From Operating Activities, Continuing | -$13.35M |
| Net Cash Flow From Investing Activities | $3.94M |
| Net Cash Flow From Investing Activities, Continuing | $3.94M |
| Net Cash Flow From Financing Activities | $9.41M |
| Net Cash Flow From Financing Activities, Continuing | $9.41M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$31.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.18M |
| Other Comprehensive Income/Loss | $0.00 |